Abera Bioscience AB (NGM:ABERA)
Sweden · Delayed Price · Currency is SEK 8.52
+0.52 (6.50%)
At close: Jun 15, 2026
Abera Bioscience AB Market Cap
Abera Bioscience AB has a market cap or net worth of 174.65 million as of June 15, 2026. Its market cap has increased by 44.00% in one year.
Market Cap
174.65M
Enterprise Value
148.61M
Revenue
11.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.52
Market Cap Chart
Since February 24, 2021, Abera Bioscience AB's market cap has increased from 115.59M to 174.65M, an increase of 51.10%. That is a compound annual growth rate of 8.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 174.65M | 39.23% |
| Dec 30, 2025 | 125.44M | 81.17% |
| Dec 30, 2024 | 69.24M | -7.23% |
| Dec 29, 2023 | 74.63M | 20.46% |
| Dec 30, 2022 | 61.96M | -64.21% |
| Dec 30, 2021 | 173.12M | 49.77% |
| Feb 24, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Crown Energy AB | 191.88M |
| Fable Media Group AB | 178.69M |
| Seamless Distribution Systems AB | 175.16M |
| Triona AB | 173.30M |
| Invoicery Group AB | 172.82M |
| Solution International Nordics AB | 161.62M |
| Xer Tech Holding AB | 160.55M |
| Prolight Diagnostics AB | 160.20M |